­
­
­
­

Inventi Impact - Cancer Nursing

  • Journal Image
    Journal Scope:

    Quarterly published in print and online ‘Inventi Rapid/Impact: Cancer Nursing’ publishes high quality unpublished as well as high impact pre-published research and reviews catering to the needs of researchers and professionals. The journal focuses on all the aspects pertaining to caring the cancer patients i.e. prevention and early detection, geriatric and pediatric cancer nursing, medical and surgical oncology, ambulatory care, nutritional support, psychosocial aspects etc.

  • A REVIEW ON AUTOMATIC MAMMOGRAPHIC DENSITY AND PARENCHYMAL SEGMENTATION
    Wenda He, Arne Juette, Erika R E Denton, Arnau Oliver, Robert Marti, Reyer Zwiggelaar    Download Full Text

    Breast cancer is themost frequently diagnosed cancer inwomen.However, the exact cause(s) of breast cancer still remains unknown. Early detection, precise identification of women at risk, and application of appropriate disease prevention measures are by far the most effective way to tackle breast cancer.There aremore than 70 common genetic susceptibility factors included in the current nonimage- ba...

    Read More
  • R.E.N.A.L. NEPHROMETRY SCORE PREDICTS POSTOPERATIVE RECURRENCE OF LOCALIZED RENAL CELL CARCINOMA TREATED BY RADICAL NEPHRECTOMY
    Akira Nagahara, Motohide Uemura, Atsunari Kawashima, Takeshi Ujike, Kazutoshi Fujita, Yasushi Miyagawa, Norio Nonomura    Download Full Text

    Background We investigated the association between the R.E.N.A.L. nephrometry score (RNS) and the postoperative recurrence of localized renal cell carcinoma (RCC). Methods We retrospectively analyzed a database comprising 91 patients with non-small localized RCC (pT1b–T2b) treated by radical nephrectomy at our hospital from January 2002 to March 2010. RNS was scored based on imaging findings at ...

    Read More
  • 5 A REDUCTASE INHIBITORS, BENIGN PROSTATIC HYPERPLASIA, AND RISK OF MALE BREAST CANCER
    David Robinson, Hans Garmo, Lars Holmberg, Par Stattin    Download Full Text

    Purpose 5-a reductase inhibitors (5-ARI) have been suggested to increase the risk of male breast cancer. The aim of this study was to study the risk of breast cancer in men on 5-ARI, in men with benign prostatic hyperplasia (BPH) not on 5-ARI, and in men without BPH. Methods We performed a population-based cohort study in Sweden with data from The Prescribed Drug Register, The Patient Register, an...

    Read More
  • BELIEFS ABOUT WEIGHT AND BREAST CANCER: AN INTERVIEW STUDY WITH HIGH RISK WOMEN FOLLOWING A 12 MONTH WEIGHT LOSS INTERVENTION
    Claire E Wright, Michelle Harvie, Anthony Howell, D Gareth Evans, Nick Hulbert-Williams, Louise S Donnelly    Download Full Text

    Background: Breast cancer is the most common cancer in the UK. Lifestyle factors including excess weight contribute to risk of developing the disease. Whilst the exact links between weight and breast cancer are still emerging, it is imperative to explore how women understand these links and if these beliefs impact on successful behaviour change. Method: Overweight/obese premenopausal women (aged 3...

    Read More
  • PATIENT EXPERIENCES LIVING WITH PANCREATIC CANCER RISK
    Meghan Underhill, Donna Berry, Emily Dalton, Jaclyn Schienda, Sapna Syngal    Download Full Text

    Background: Pancreatic cancer (PancCa) is recognized as a component of many well-described hereditary cancer syndromes. Minimal research has focused on patient needs and experiences living with this risk. Purpose: To understand the meaning and experience of living with familial PancCa risk and to explore experiences related to screening and prevention of PancCa. Methods: Participants underwent sem...

    Read More
  • TUMOUR SPECTRUM IN NON-BRCA HEREDITARY BREAST CANCER FAMILIES IN SWEDEN
    Camilla Wendt, Annika Lindblom, Brita Arver, Anna von Wachenfeldt, Sara Margolin    Download Full Text

    Background: Approximately 30 % of all breast cancer is at least partly attributed to hereditary factors. Familial breast cancer is often inherited in the context of cancer syndromes. The most commonly mutated genes are BRCA1 and BRCA2 in hereditary breast and ovarian cancer syndrome. The genetic background in families with hereditary breast cancer without predisposing germ line mutations in BRCA1 ...

    Read More